ProCE Banner Activity

PERSIST-1: Reduction in Spleen Volume and Symptom Scores in MF With Pacritinib vs BAT

Slideset Download
Conference Coverage
Benefits from pacritinib observed regardless of baseline characteristics, including platelet count.

Released: December 10, 2015

Expiration: December 08, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen